3 ms·
and here I thought we might have compatible points. In the hypothetical where it is demonstrated to be effective, I don't think it is ethical to suppress the u
by s1artibartfast 5y ago
and here I thought we might have compatible points.
In the hypothetical where it is demonstrated to be effective, I don't think it is ethical to suppress the use of one effective treatment to incentivize uptake of another (vaccination). That is to say, we shouldn't deny treatment with an effective treatment or post exposure prophylatic because it might embolden other people to forgo an earlier intervention (vaccination).
Your supply objection is a valid concern, but not absolute. I agree populations with parasites should get first priority if their relative benefit is greater. That said, there is additional manufacturing capacity and the ability to easily expand it. If you say excess supply cannot be used, this is the same as your argument above.